/ Print /

MHE Articles

Risk-contract engagement strategies should differ for independent, employed docsIf your organization is managing a risk-based contract, you are likely working hard to engage physicians. But are you modifying those efforts based on whether physicians are independent or employed? Here’s why you should.
Four oncology treatment advances to watch
Four oncology treatment advances to watchExperts say a cancer care revolution is here. Here’s a closer look at some advancements in cancer treatments to watch.
Genetic testing: 3 things managed healthcare executives should knowA new survey on genetic testing has surprisingly results on consumer acceptance and impact for healthcare executives.
Top 11 pieces of advice for young healthcare executivesWe asked successful healthcare industry leaders to share their top tips for young executives. Here’s what they said.
Top 5 consumer health concernsA new survey from consumer health companies has revealing findings about American health and well-being.
Top two concerns for healthcare executives in 2018A survey unveiled at the HealthCare Executive Group’s Annual Forum divulges surprising findings about healthcare technology and innovation.
Five questions for payers to ask when deciding coverage of genomic testsGenetics and genomics are starting to have an impact on cardiovascular care. Here’s what payers should consider when deciding whether to cover a gene expression test.
Here’s a more effective way to test for HPVA Kaiser Permanente study found that a new way to test for HPV has the potential to increase efficiency and decrease waste.
CMS plan to slash 340B payments under fire by hospitalsHere are four ways CMS’ final rule related to the 340B Drug Pricing Program could affect the healthcare industry.
Controversy heats up over pharmacy benefit manager DIR feesPBMs make the argument for DIR fees after a litany of complaints from industry stakeholders.